Mechanisms of Spiroplasma eriocheiris Entry via Endocytosis in S2 Cells

Study Background and Research Question

Spiroplasma eriocheiris is a pathogenic, wall-less prokaryote noted for significant economic impacts in crustacean aquaculture. While its pathogenicity had been observed in various hosts—including crustaceans, chicken embryos, and mice—cellular mechanisms underlying its entry into invertebrate host cells remained uncharacterized. The reference study by Wei et al. (2019) addressed this gap by establishing a Drosophila Schneider 2 (S2) cell infection model to investigate the invasion pathways exploited by S. eriocheiris (paper).

Key Innovation from the Reference Study

Wei et al. demonstrated, for the first time, that S. eriocheiris can actively invade Drosophila S2 cells through specific endocytic pathways. Their use of targeted pharmacological inhibitors, including those affecting clathrin-mediated endocytosis and macropinocytosis, provided mechanistic clarity on the cellular entry process. The study establishes a robust, invertebrate-relevant cellular model, highlighting the distinctiveness of S2 cells in recapitulating crustacean infection biology (paper).

Methods and Experimental Design Insights

The authors infected Drosophila S2 cells with S. eriocheiris and employed quantitative PCR to monitor intracellular bacterial load over time. Cell viability, apoptosis, and necrosis were assessed using standard assays, while transmission electron microscopy and fluorescence imaging revealed morphological alterations such as inclusion body formation and vacuolization. To dissect endocytic pathways, the team applied a panel of pharmacological inhibitors:

• Chlorpromazine (a canonical dopamine receptor antagonist and clathrin-mediated endocytosis blocker)
• Dynasore (dynamin inhibitor)
• Macropinocytosis inhibitors (targeting protein kinase C and myosin II)
• Cytoskeletal disruptors (nocodazole for microtubules, cytochalasin B for actin filaments)
• Cholesterol-disrupting agents targeting caveolae-dependent endocytosis

This combinatorial inhibitor approach enabled the authors to delineate entry routes by observing the impact on bacterial internalization and cell pathology (paper).

Core Findings and Why They Matter

The central discoveries can be summarized as follows:

• Active S2 Cell Invasion: S. eriocheiris robustly enters S2 cells, with intracellular bacterial copies peaking at 12 hours post-infection (paper).
• Endocytosis Pathway Specificity: Blocking clathrin-mediated endocytosis with chlorpromazine or dynasore significantly reduced S. eriocheiris entry, implicating this pathway as essential. Inhibition of macropinocytosis also suppressed bacterial internalization.
• Caveola-Independent Entry: Disruption of cholesterol-rich domains (methyl-β-cyclodextrin, nystatin) did not alter infection rates, ruling out caveola-mediated endocytosis.
• Cytoskeletal Dependence: Microtubule and actin filament disruption sharply diminished bacterial uptake, underscoring cytoskeletal involvement.
• Host Cell Response: Infection induced apoptosis, necrosis, increased reactive oxygen species, and characteristic inclusion body formation in S2 cells.

Collectively, these results provide the first mechanistic map of S. eriocheiris entry into invertebrate cells, with direct implications for understanding host-pathogen dynamics and for developing intervention strategies in aquaculture and comparative cell biology (paper).

Comparison with Existing Internal Articles

Recent internal resources have contextualized the use of clathrin-mediated endocytosis inhibitors—including Chlorpromazine HCl—in both neuropharmacology and cell biology workflows. For example, the article “Chlorpromazine HCl: Core Evidence for Dopamine Antagonism and Cell Biology” highlights the dual role of Chlorpromazine HCl as a dopamine receptor antagonist and as a robust tool for endocytic pathway dissection in cell-based assays (internal_article). This aligns with Wei et al.’s use of chlorpromazine to confirm the clathrin dependence of S. eriocheiris entry. Similarly, “Chlorpromazine HCl: Applied Workflows in Neuropharmacology and Cell Biology” offers protocol-driven guidance for leveraging this compound in reproducible studies of cellular entry and viability (internal_article). Notably, the reference study expands the application of such inhibitors beyond mammalian or neural systems, demonstrating their relevance in invertebrate models and pathogen-host interaction studies.

Limitations and Transferability

While this study establishes Drosophila S2 cells as a tractable model for S. eriocheiris infection, there are limitations to direct translatability. S2 cells, though phylogenetically closer to crustacean cells than mammalian lines, are not crustacean-derived, and subtle differences in endocytic machinery or immune responses may exist. Additionally, pharmacological inhibitors such as chlorpromazine can have off-target effects—including dopamine receptor inhibition and membrane perturbation—which should be considered when interpreting pathway specificity (paper). Nevertheless, the model provides a valuable platform for dissecting pathogen entry and host defense mechanisms in invertebrate systems.

Protocol Parameters

• cell-based endocytosis assay | 10–100 μM Chlorpromazine HCl | S2 cells, mammalian cells | Standard range for effective clathrin-mediated endocytosis inhibition while monitoring cell viability | paper, product_spec
• dynamin inhibition (control) | 80 μM dynasore | S2 cells | Benchmarked as a comparative inhibitor for clathrin-mediated entry | paper
• macropinocytosis inhibition | 1–10 μM EIPA, 10 μM cytochalasin B | S2 cells | Blockade of actin-dependent uptake processes | paper, workflow_recommendation
• cell viability/cytotoxicity | as per standard MTT or LDH assay | S2 cells | To ensure assay specificity and minimize confounding cytotoxicity | workflow_recommendation

Research Support Resources

Researchers aiming to replicate or extend these findings can utilize Chlorpromazine HCl (SKU B1480), a well-characterized dopamine receptor antagonist with validated utility in blocking clathrin-mediated endocytosis for in vitro cell biology assays (source: product_spec). For detailed application protocols and troubleshooting, the workflow resources provided by APExBIO and internal review articles offer practical guidance. Proper concentration selection (typically 10–100 μM for endocytosis studies) and attention to storage and solution stability are recommended to ensure reproducible results (source: product_spec, workflow_recommendation).